Cancer Diagnostics Market is estimated to be US$ 46.29 billion by 2030 with a CAGR of 11.50% during the forecast period prophecymarketinsights.com
The report " Global Cancer Diagnostics Market, By Method (Enzyme-Linked Immunosorbent Assay (ELISA), Enzyme-Linked Fluorescent Assay (ELFA), Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunohistochemistry, Microarray, Imaging, Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), Positron Emission Tomography (PET), Ultrasound, Mammography, Biopsy, and Others), By Disease Indication (Breast cancer, Colorectal cancer, Cervical cancer, Lung cancer, Prostate cancer, Skin cancer, Blood cancer, Kidney cancer, Liver cancer, Pancreatic cancer, Ovarian Cancer, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) – Trends, Analysis, and Forecast till 2030”
Report Story
Leave Your Comment